Search Results Search Sort by RelevanceMost Recent Viewpoint Jan 2021 The Nazi Analogy Muddles Our Thinking About Physician Aid-in-Dying in the US Holland M. Kaplan, MD Carefully distinguishing between when the Nazi analogy is aptly applied and when it is not is key to ongoing PAD legalization deliberations. AMA J Ethics. 2021;23(1):E78-81. doi: 10.1001/amajethics.2021.78 History of Medicine Nov 2017 How Co-Creation Helped Address Hierarchy, Overwhelmed Patients, and Conflicts of Interest in Health Care Quality and Safety Sigal Israilov and Hyung J. Cho, MD Co-creative health systems planning requires engaging patients and learning from peers. AMA J Ethics. 2017;19(11):1139-1145. doi: 10.1001/journalofethics.2017.19.11.mhst1-1711. Art of Medicine May 2019 Fading Mind of a Patient With Alzheimer’s Laci Hadorn This artwork represents—via a puzzle—physical and emotional experiences of brain deterioration. AMA J Ethics. 2019;21(5):E455-456. doi: 10.1001/amajethics.2019.455. Medical Education Aug 2020 What Clinicians and Health Professions Students Should Learn About How Pharmaceutical Marketing Influences Opioid Prescribing and Patient Outcomes Michael A. Erdek, MD, MA Key policy changes would better situate clinicians to prescribe care in ways that are ethical, safe, and effective. AMA J Ethics. 2020;22(8):E681-686. doi: 10.1001/amajethics.2020.681. Viewpoint May 2022 Reimagining Roles of Dietary Supplements in Psychiatric Care Katherine Wu, MD and Erik Messamore, MD, PhD Government-supported review and safety monitoring is needed for dietary supplements’ use in the care of patients with mental illness. AMA J Ethics. 2022;24(5):E437-442. doi: 10.1001/amajethics.2022.437. Podcast May 2022 Author Interview: “Reimagining Roles of Dietary Supplements in Psychiatric Care” Dr Katherine Wu joins Ethics Talk to discuss her article, coauthored with Dr Erik Messamore: “Reimagining Roles of Dietary Supplements in Psychiatric Care.” Health Law Dec 2016 The Legal Implications of Detecting Alzheimer’s Disease Earlier Joshua Preston, Jaleh McTeigue, Caitlin Opperman, Jordan Dean Scott Krieg, Mikaela Brandt-Fontaine, Alina Yasis, and Francis X. Shen, JD, PhD What are insurance, contract, and criminal law implications of detecting Alzheimer’s disease early? AMA J Ethics. 2016;18(12):1207-1217. doi: 10.1001/journalofethics.2016.18.12.hlaw1-1612. Medicine and Society Aug 2004 Presymptomatic Genetic Testing for Neurodegenerative Diseases Shane K. Green, PhD Virtual Mentor. 2004;6(8):360-363. doi: 10.1001/virtualmentor.2004.6.8.msoc1-0408. Medicine and Society Oct 2023 What Might Aducanumab Teach Us About Clinicians’ Judgment About Whether to Recommend Emerging Alzheimer’s Interventions? Adam W. Burroughs, MD and Lewis P. Krain, MD Ethics questions about care of patients with AD could influence clinicians’ judgment about whether and when to recommend aducanumab. AMA J Ethics. 2023;25(10):E777-782. doi: 10.1001/amajethics.2023.777. Case and Commentary Jul 2017 How Should Clinicians Counsel a Woman with a Strong Family History of Early-Onset Alzheimer’s Disease about Her Pregnancy? Marianna V. Mapes, Barbara M. O'Brien, MD, and Louise P. King, MD, JD Pregnant women at high risk for heritable diseases need support and nondirective genetic counseling. AMA J Ethics. 2017;19(7):663-674. doi: 10.1001/journalofethics.2017.19.7.ecas4-1707. Pagination Current page 1 Page 2 Page 3 Page 4 Next page Next › Last page Last »
Viewpoint Jan 2021 The Nazi Analogy Muddles Our Thinking About Physician Aid-in-Dying in the US Holland M. Kaplan, MD Carefully distinguishing between when the Nazi analogy is aptly applied and when it is not is key to ongoing PAD legalization deliberations. AMA J Ethics. 2021;23(1):E78-81. doi: 10.1001/amajethics.2021.78
History of Medicine Nov 2017 How Co-Creation Helped Address Hierarchy, Overwhelmed Patients, and Conflicts of Interest in Health Care Quality and Safety Sigal Israilov and Hyung J. Cho, MD Co-creative health systems planning requires engaging patients and learning from peers. AMA J Ethics. 2017;19(11):1139-1145. doi: 10.1001/journalofethics.2017.19.11.mhst1-1711.
Art of Medicine May 2019 Fading Mind of a Patient With Alzheimer’s Laci Hadorn This artwork represents—via a puzzle—physical and emotional experiences of brain deterioration. AMA J Ethics. 2019;21(5):E455-456. doi: 10.1001/amajethics.2019.455.
Medical Education Aug 2020 What Clinicians and Health Professions Students Should Learn About How Pharmaceutical Marketing Influences Opioid Prescribing and Patient Outcomes Michael A. Erdek, MD, MA Key policy changes would better situate clinicians to prescribe care in ways that are ethical, safe, and effective. AMA J Ethics. 2020;22(8):E681-686. doi: 10.1001/amajethics.2020.681.
Viewpoint May 2022 Reimagining Roles of Dietary Supplements in Psychiatric Care Katherine Wu, MD and Erik Messamore, MD, PhD Government-supported review and safety monitoring is needed for dietary supplements’ use in the care of patients with mental illness. AMA J Ethics. 2022;24(5):E437-442. doi: 10.1001/amajethics.2022.437.
Podcast May 2022 Author Interview: “Reimagining Roles of Dietary Supplements in Psychiatric Care” Dr Katherine Wu joins Ethics Talk to discuss her article, coauthored with Dr Erik Messamore: “Reimagining Roles of Dietary Supplements in Psychiatric Care.”
Health Law Dec 2016 The Legal Implications of Detecting Alzheimer’s Disease Earlier Joshua Preston, Jaleh McTeigue, Caitlin Opperman, Jordan Dean Scott Krieg, Mikaela Brandt-Fontaine, Alina Yasis, and Francis X. Shen, JD, PhD What are insurance, contract, and criminal law implications of detecting Alzheimer’s disease early? AMA J Ethics. 2016;18(12):1207-1217. doi: 10.1001/journalofethics.2016.18.12.hlaw1-1612.
Medicine and Society Aug 2004 Presymptomatic Genetic Testing for Neurodegenerative Diseases Shane K. Green, PhD Virtual Mentor. 2004;6(8):360-363. doi: 10.1001/virtualmentor.2004.6.8.msoc1-0408.
Medicine and Society Oct 2023 What Might Aducanumab Teach Us About Clinicians’ Judgment About Whether to Recommend Emerging Alzheimer’s Interventions? Adam W. Burroughs, MD and Lewis P. Krain, MD Ethics questions about care of patients with AD could influence clinicians’ judgment about whether and when to recommend aducanumab. AMA J Ethics. 2023;25(10):E777-782. doi: 10.1001/amajethics.2023.777.
Case and Commentary Jul 2017 How Should Clinicians Counsel a Woman with a Strong Family History of Early-Onset Alzheimer’s Disease about Her Pregnancy? Marianna V. Mapes, Barbara M. O'Brien, MD, and Louise P. King, MD, JD Pregnant women at high risk for heritable diseases need support and nondirective genetic counseling. AMA J Ethics. 2017;19(7):663-674. doi: 10.1001/journalofethics.2017.19.7.ecas4-1707.